HCA Healthcare, Inc. (HCA): who owns it and who trades it
As of Nov 16, 2026, HCA insiders reported 22 open-market sales worth $47.5M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Samuel N Hazen (CEO), with $21.5M. 10 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling HCA Healthcare
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Congress mostly bought. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns HCA
1,335 funds and institutions reported HCA shares worth $52.9B at the end of Q2 2026, about 61% of the company. The largest holder is BlackRock, Inc. with 5.9%.
Funds and institutions (13F) 61%Everyone else 39%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 13.00M | 5.86% | $5.1B | -3% |
| Vanguard Capital Management LLC | 10.14M | 4.57% | $4B | -0% |
| Sanders Capital, LLC | 8.83M | 3.98% | $3.4B | -1% |
| State Street Corp | 7.47M | 3.37% | $2.9B | -1% |
| First Eagle Investment Management, LLC | 6.59M | 2.97% | $2.6B | +103% |
| Wellington Management Group LLP | 4.71M | 2.12% | $1.8B | +20% |
| Geode Capital Management, LLC | 3.67M | 1.65% | $1.4B | -1% |
| Vanguard Portfolio Management LLC | 2.71M | 1.22% | $1.1B | -2% |
| Morgan Stanley | 2.59M | 1.17% | $1B | +13% |
| Goldman Sachs Group Inc | 2.46M | 1.11% | $961M | +15% |
| JPMorgan Chase & Co | 2.29M | 1.03% | $897M | – |
| Arrowstreet Capital, Limited Partnership | 2.21M | 1.00% | $861M | +2% |
| Norges Bank | 2.15M | 0.97% | $836M | – |
| Capital World Investors | 1.98M | 0.89% | $771M | +0% |
| Capital International Investors | 1.92M | 0.86% | $747M | -37% |
| Northern Trust Corp | 1.71M | 0.77% | $666M | -2% |
| FMR LLC (Fidelity) | 1.63M | 0.74% | $637M | -63% |
| Invesco Ltd. | 1.53M | 0.69% | $596M | +6% |
| Nordea Investment Management AB | 1.43M | 0.64% | $554M | -1% |
| Barclays PLC | 1.32M | 0.59% | $514M | +6% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, HCA insiders reported $0 of open-market purchases and $47.5M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Erica Rossitto | Vice president | Sale | 3,500 | $505.81 | $1.8M | Form 4 |
| Nov 6, 2026 | Jon M Foster | Vice president | Sale | 890 | $498.97 | $444K | Form 4 |
| Nov 6, 2026 | Jon M Foster | Vice president | Sale | 1,684 | $498.00 | $839K | Form 4 |
| Nov 6, 2026 | Jon M Foster | Vice president | Sale | 1,066 | $496.92 | $530K | Form 4 |
| Nov 6, 2026 | Jon M Foster | Vice president | Sale | 2,692 | $495.85 | $1.3M | Form 4 |
| Nov 6, 2026 | Jon M Foster | Vice president | Sale | 7,595 | $494.91 | $3.8M | Form 4 |
| Nov 6, 2026 | Jon M Foster | Vice president | Sale | 6,302 | $493.58 | $3.1M | Form 4 |
| Nov 6, 2026 | Jon M Foster | Vice president | Sale | 1,484 | $491.98 | $730K | Form 4 |
| Nov 4, 2026 | Jon M Foster | Vice president | Sale | 10,000 | $514.07 | $5.1M | Form 4 |
| Nov 4, 2026 | Michael J Schlosser | Vice president | Sale | 1,200 | $494.65 | $594K | Form 4 |
| Feb 18, 2026 | Michael R McAlevey | Vice president | Sale | 1,694 | $533.37 | $904K | Form 4 |
| Feb 11, 2026 | Christopher F. Wyatt | Vice president | Sale | 4,000 | $505.00 | $2M | Form 4 |
| Feb 11, 2026 | Jennifer Berres | Vice president | Sale | 4,010 | $526.16 | $2.1M | Form 4 |
| Feb 11, 2026 | Jennifer Berres | Vice president | Sale | 4,010 | $503.00 | $2M | Form 4 |
| Feb 3, 2026 | Samuel N Hazen | CEO | Sale | 14,716 | $502.95 | $7.4M | Form 4 |
| Feb 3, 2026 | Samuel N Hazen | CEO | Sale | 5,002 | $502.15 | $2.5M | Form 4 |
| Feb 3, 2026 | Samuel N Hazen | CEO | Sale | 7,395 | $500.69 | $3.7M | Form 4 |
| Feb 3, 2026 | Samuel N Hazen | CEO | Sale | 6,189 | $500.02 | $3.1M | Form 4 |
| Feb 3, 2026 | Samuel N Hazen | CEO | Sale | 5,162 | $498.80 | $2.6M | Form 4 |
| Feb 3, 2026 | Samuel N Hazen | CEO | Sale | 4,293 | $498.12 | $2.1M | Form 4 |
| Feb 3, 2026 | Samuel N Hazen | CEO | Sale | 120 | $497.18 | $59.7K | Form 4 |
| Feb 3, 2026 | Michael S. Cuffe | Vice president | Sale | 1,500 | $498.09 | $747K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Samuel N Hazen | CEO, Director | – | $21.5M | Feb 3, 2026 |
| Jon M Foster | EVP and COO | – | $15.9M | Nov 6, 2026 |
| Jennifer Berres | SVP & Chief Human Res. Officer | – | $4.1M | Feb 11, 2026 |
| Christopher F. Wyatt | SVP & Controller | – | $2M | Feb 11, 2026 |
| Erica Rossitto | SVP & Chief Nurse Executive | – | $1.8M | Nov 10, 2026 |
| Michael R McAlevey | EVP & Chief Legal & Admin Off. | – | $904K | Feb 18, 2026 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | – | $747K | Feb 3, 2026 |
| Michael J Schlosser | EVP and Chief Clinical Officer | – | $594K | Nov 4, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
HCA short interest
Low short interest. 2.3% of HCA shares are sold short: about 1 share in 44. Over the last 12 reports the number of shares short went up 8%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.80M HCA shares were sold short, 2.3% of the shares outstanding, down 2.1% from the report before. At the average daily volume of 1.45M shares, buying them all back would take about 3.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.80M | 2.30% | -2% | 1.45M | 3.3 |
| Oct 15, 2026 | 4.91M | 2.27% | +0% | 1.07M | 4.6 |
| Sep 30, 2026 | 4.88M | 2.26% | -25% | 1.59M | 3.1 |
| Sep 15, 2026 | 6.48M | 2.99% | +6% | 1.43M | 4.5 |
| Aug 31, 2026 | 6.14M | 2.83% | +0% | 1.25M | 4.9 |
| Aug 14, 2026 | 6.13M | 2.83% | +1% | 1.10M | 5.6 |
| Jul 31, 2026 | 6.06M | 2.80% | +4% | 1.72M | 3.5 |
| Jul 15, 2026 | 5.83M | 2.63% | +9% | 1.86M | 3.1 |
| Jun 30, 2026 | 5.35M | 2.41% | +3% | 1.54M | 3.5 |
| Jun 15, 2026 | 5.21M | 2.35% | No change | 1.93M | 2.7 |
| May 29, 2026 | 5.21M | 2.35% | +17% | 1.76M | 3.0 |
| May 15, 2026 | 4.45M | 2.01% | +3% | 1.23M | 3.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded HCA
Since Nov 17, 2024, 6 members of Congress reported 6 purchases and 4 sales of HCA. The latest was a purchase by Jared Moskowitz on Jun 17, 2026, reported Jul 26, 2026.
Purchases 6Sales 4
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Jared Moskowitz (D-FL) | Purchase | $1K–$15K | Child | Jul 26, 2026 | Report |
| Jun 17, 2026 | Jared Moskowitz (D-FL) | Purchase | $1K–$15K | Self | Jul 26, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Sep 11, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Oct 22, 2025 | Report |
| Aug 19, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Sep 12, 2025 | Report |
| May 15, 2025 | Jared Moskowitz (D-FL) | Purchase | $1K–$15K | Self | Jun 27, 2025 | Report |
| May 15, 2025 | Jared Moskowitz (D-FL) | Purchase | $1K–$15K | Child | Jun 27, 2025 | Report |
| Apr 7, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | May 14, 2025 | Report |
| Feb 25, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $1K–$15K | Self | Mar 27, 2025 | Report |
| Dec 27, 2024 | Val T. Hoyle (D-OR) | Sale | $1K–$15K | Spouse | Sep 12, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
HCA Healthcare company events
HCA Healthcare filed 13 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026AgreementHCA Inc., a direct, wholly owned subsidiary of HCA Healthcare, Inc., completed the public offering of (i) $500 million of its 5.200% Senior Notes due 2028, (ii) $300 million of its Floating Rate Senior Notes due 2028, (iii) $1 billion of its 5.350% Senior Notes due 2029, (iv) $1.25 billion of its… Filing
- Nov 2, 2026AnnouncementHCA Healthcare, Inc. issued a press release announcing the commencement of its proposed public offering by HCA Inc., a direct, wholly owned subsidiary of the Registrant, of senior unsecured notes. Filing
- Oct 27, 2026AnnouncementThe Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock. Filing
- Jul 29, 2026AnnouncementBelow is incorporated by reference into this Item 2.03. Filing
- Jul 24, 2026AnnouncementThe Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock. Filing
- Jul 14, 2026ResultsReleased financial results. Filing
- Jun 18, 2026LeadershipDr. Michael Cuffe and HCA Healthcare, Inc. agreed that Dr. Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, and thereafter continue in a transitional role with the Company until February 2027. Filing
- Apr 30, 2026AgreementHCA Inc., a direct, wholly owned subsidiary of HCA Healthcare, Inc., completed the public offering of (i) $1 billion of its 4.700% Senior Notes due 2031, (ii) $750 million of its 5.000% Senior Notes due 2033 and (iii) $1.25 billion of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together… Filing
- Apr 28, 2026VoteReported shareholder vote results. Filing
- Apr 27, 2026AnnouncementHCA Healthcare, Inc. issued a press release announcing the commencement of its proposed public offering by HCA Inc., a direct, wholly owned subsidiary of the Registrant, of senior unsecured notes. Filing
- Apr 24, 2026AnnouncementThe Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock. Filing
- Feb 25, 2026LeadershipThe Compensation Committee of the Board of Directors of HCA Healthcare, Inc. adopted the 2026 Executive Officer Performance Excellence Program. Filing
- Jan 27, 2026AnnouncementThe Company announced that its Board of Directors had authorized an additional share repurchase program for up to $10 billion of the Company’s outstanding common stock. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
HCA Healthcare financials
Famous investors that hold HCA
10 of the 50 well-known investors we track reported holding HCA in their latest 13F filing. The largest position is Ray Dalio's, worth $86.3M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ray Dalio · Bridgewater Associates | Q3 2026 | 202,141 | $86.3M | 0.4% | -1% |
| Israel Englander · Millennium Management | Q3 2026 | 165,181 | $70.5M | 0.1% | +158% |
| Bill Nygren · Harris Associates (Oakmark) | Q3 2026 | 152,896 | $65.2M | 0.1% | -1% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 102,951 | $43.9M | 0.0% | -44% |
| Richard Pzena · Pzena Investment Management | Q3 2026 | 99,648 | $42.5M | 0.1% | +3% |
| Tom Gayner · Markel Group | Q3 2026 | 84,972 | $36.3M | 0.3% | +1% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 6,380 | $2.7M | 0.0% | New |
| Glenn Greenberg · Brave Warrior Advisors | Q3 2026 | 4,666 | $2M | 0.0% | -3% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 3,319 | $1.4M | 0.0% | New |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 2,491 | $1.1M | 0.0% | -17% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named HCA in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 6, 2026 | Frisco Holding II | 13D/A | 18.6% |
| Nov 6, 2026 | Frisco Holding II | 13D/A | 18.6% |
Questions about HCA Healthcare, Inc. (HCA) stock
Who owns the most HCA stock?
The largest reported owner of HCA Healthcare, Inc. (HCA) is BlackRock, Inc., with 5.9% of the company. In total, 1,335 funds and institutions reported holding HCA at the end of Q2 2026, together about 61% of the shares. See the largest owners.
Are HCA insiders buying or selling?
In the last 12 months, HCA insiders reported no open-market purchases and 22 sales worth $47.5M. The latest trade was on Nov 10, 2026. See every trade.
What is the short interest in HCA?
As of Oct 30, 2026, 4.80M HCA shares were sold short, 2.3% of the shares outstanding, down 2.1% from the report before. At the average daily volume of 1.45M shares, buying them all back would take about 3.3 trading days (days to cover). See the history.
Have members of Congress traded HCA?
Yes. 6 members of Congress reported 6 purchases and 4 sales of HCA since Nov 17, 2024. The latest was reported on Jul 26, 2026. See the trades.
Which famous investors hold HCA?
10 of the 50 well-known investors we track reported HCA in their latest 13F filing, including Ray Dalio, Israel Englander, Bill Nygren. The largest position is worth $86.3M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.